Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Not yet recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma, Large B-Cell, Diffuse 39Lymphoma 34Lymphoma, Follicular 24Lymphoma, Non-Hodgkin 23Lymphoma, Mantle-Cell 19Lymphoma, B-Cell 16Leukemia, Lymphocytic, Chronic, B-Cell 16Precursor Cell Lymphoblastic Leukemia-Lymphoma 15Multiple Myeloma 15Burkitt Lymphoma 14Lymphoma, B-Cell, Marginal Zone 13Hodgkin Disease 13Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 8Lymphoma, Large-Cell, Anaplastic 8Glioma 8Neuroectodermal Tumors, Primitive, Peripheral 7Neuroblastoma 7Mycosis Fungoides 7Lymphoma, T-Cell 7Histiocytosis, Langerhans-Cell 7Wilms Tumor 6Waldenstrom Macroglobulinemia 6Sarcoma 6Rhabdoid Tumor 6Medulloblastoma 6Lymphoma, T-Cell, Cutaneous 6Hepatoblastoma 6Ependymoma 6Rhabdomyosarcoma 5Osteosarcoma 5

Interventions

Etoposide 6Vincristine 5Prednisone 5Doxorubicin 5Cyclophosphamide 5Rituximab 4prednylidene 3deltacortene 3daratumumab 2Cytarabine 2varlilumab 1pomalidomide 1merphos 1ixazomib 1carmustine, poliferprosan 20 drug combination 1belantamab mafodotin 1Vorinostat 1Specimen Handling 1Peripheral Blood Stem Cell Transplantation 1Nivolumab 1Methotrexate 1Melphalan 1Magnetic Resonance Spectroscopy 1Immunoglobulin G 1Hydrocortisone 1Disulfides 1Dexamethasone 1Carmustine 1CT-P10 1Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Plasmablastic Lymphoma × Magnetic Resonance Spectroscopy × Lymphoid × Clear all
NCT07332507 2026-05-13

Testing the Effect of Teclistamab on Recurrent Plasmablastic Lymphoma

National Cancer Institute (NCI)

Phase 1 Not yet recruiting
30 enrolled
Lymphoid

Plasmablastic Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡